5-hydroxytryptophan (5-HTP) in Down's syndrome.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004314:Down Syndrome / Q000097:blood / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid / Q000652:urine; D007211:Indoles / Q000097:blood / Q000134:cerebrospinal fluid; D007223:Infant; D008607:Intellectual Disability / Q000188:drug therapy / Q000209:etiology; D008297:Male; D009043:Motor Activity; D009129:Muscle Tonus; D009460:Neurologic Examination; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D012890:Sleep; D014314:Trisomy
D007211:Indoles; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan